By modifying the expression of NF-kB and BDNF, naringenin alleviates depression and anxiety-like behaviors in mice subjected to repeated hypoxic stress; however, using the gut–brain axis experimental parameters, there is a need to determine the involvement of naringenin in the gut–brain axis pathway to reduce depression [97]. This evidence concerns the gene NFKB1 and depressive symptom measurement.